3-imidazolyl-indoles for the treatment of proliferative diseases

Details for Australian Patent Application No. 2008234954 (hide)

Owner Novartis AG

Inventors Hergovich Lisztwan, Joanna; Kallen, Jorg; Boettcher, Andreas; Masuya, Keiichi; Vaupel, Andrea; Furet, Pascal; Mayr, Lorenz; Buschmann, Nicole; Groell, Jean-Marc

Agent Davies Collison Cave

Pub. Number AU-B-2008234954

PCT Pub. Number WO2008/119741

Priority 07105269.0 29.03.07 EP

Filing date 27 March 2008

Wipo publication date 9 October 2008

Acceptance publication date 27 October 2011

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/119741 Priority application(s): WO2008/119741

27 October 2011 Application Accepted

  Published as AU-B-2008234954

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008234957-Heterocyclic spiro-compounds

2008234951-Enzyme for the production of methylmalonyl coenzyme A or ethylmalonyl coenzyme A, and use thereof